Business Development Strategy
SOTIO is part of the PPF Group, one of the largest investment groups in Central and Eastern Europe (www.ppf.eu). In 2012 PPF made a strategic decision to enter the biotechnology sector. PPF has a vision to build a diversified biotech portfolio of innovative therapies for the treatment of cancer.
What we are looking for
SOTIO is leading the effort of PPF to build a diverse oncology product pipeline. We seek to add to our portfolio innovative therapeutic projects in oncology with a focus on late preclinical or early clinical stage. We are looking for differentiated drugs of different modalities (small molecules, biologics, cell therapies, oncolytic viruses or vaccines) that may provide a true difference for patients suffering from cancer.
We consider each deal to be unique and we are open to various deal structures:
- Minority investments
- Mergers & Acquisitions
If you have an attractive program that you would like to introduce to us please contact our Business Development Team.
In collaboration, we are able to contribute not only financial resources but also clinical and regulatory expertise to rapidly drive preclinical and clinical development of the partnered assets. For more information please visit Our capabilities section.